Kyle Simonetta

by dividef | Mar 14, 2023

Kyle is a biochemist and structural biologist, with a passion for identifying and progressing small molecules that modulate protein-protein interactions, especially those that form cooperative ternary complexes. At Interline, Kyle leads a team of talented scientists...

Anj Saha

by dividef | Mar 14, 2023

Anj joined Interline Therapeutics in January 2021. Prior to that he was an EIR at 5AM Ventures, where he was involved with several early seed companies. Previously, he was at Nurix Therapeutics, where he built and headed the Lead Discovery department. There his team...

Scott Rosenberg

by dividef | Mar 14, 2023

Scott earned his Ph.D. in molecular and structural biology from UC San Diego in the laboratory of Dr. Kevin Corbett. He subsequently did a Postdoctoral fellowship at Genentech in the department of Discovery Oncology under Dr. Shiva Malek. During his time at Genentech,...

Hart Rardin

by dividef | Mar 14, 2023

Hart is an immunologist interested in the causes of aberrant inflammation that lead to inflammatory diseases. She has over ten years of experience at Genentech as a scientific researcher focused on small molecule therapeutics where she was involved in inhaled JAK1...

Meera Rao

by dividef | Mar 14, 2023

Meera is a medicinal chemist at Interline. She obtained her Ph.D. from Stanford University, where she developed chiral ruthenium catalysts for cycloisomerization reactions. Meera then completed postdoctoral work at UC Berkeley, where she studied polymer additive...